Clinical Trials Logo

Clinical Trial Summary

A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5-1


Clinical Trial Description

A single-center study on the effect of systemic/selective lymph node dissection on the prognosis of ground glass nodules smaller than 3cm and with components with consolidation/tumor ratio between 0.5-1 ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05184829
Study type Interventional
Source Shanghai Zhongshan Hospital
Contact
Status Not yet recruiting
Phase N/A
Start date January 1, 2022
Completion date December 31, 2029

See also
  Status Clinical Trial Phase
Recruiting NCT04581122 - A Multiple-center Study on the Effect of Different Ways of Lymph Node Dissection on the Prognosis of Ground Glass Nodules Smaller Than 3cm and With More Than 50% Solid Components N/A
Recruiting NCT03509779 - Pronostic and Predictive Value of EMT in Localized Lung Cancer
Recruiting NCT05153330 - Ph1 FIH Dose-escalation and Dose-expansion Study of BMF-219, in Adult Patients With Acute Leukemia Phase 1
Recruiting NCT04422223 - Prospective Cohort Study of Disease and Outcomes in Cirrhosis
Recruiting NCT04682457 - Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age.
Recruiting NCT03121768 - A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) N/A
Completed NCT01980212 - Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer
Recruiting NCT03582527 - PD-L1 Expression in Advanced Osteosarcoma
Completed NCT01651078 - Laser Ablation After Stereotactic Radiosurgery
Recruiting NCT02761070 - Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III Phase 3
Enrolling by invitation NCT03451929 - Kidney Function and Cardiovascular Events: Cohort Study in General Population N/A
Recruiting NCT04905056 - A Prospective, Two-center, Single Arm Phase II Clinical Study to Evaluate Safety and Effectiveness of Ablation Therapy in the Treatment of Lung Cancer Presenting as Ground-glass Nodules Phase 2
Recruiting NCT04525833 - Liver Disease and Other Systemic Diseases
Recruiting NCT04844437 - Intrapartum Translabial Ultrasonography Reliability
Recruiting NCT04213664 - Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.
Completed NCT01425112 - Comparison of Subconjuctival Versus Topical Bevacizumab as Adjunct Therapy to Trabeculectomy N/A
Not yet recruiting NCT04974671 - Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma Phase 2
Withdrawn NCT04044378 - Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma Phase 1/Phase 2
Completed NCT04491994 - Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression Phase 3